共 45 条
- [1] Cost-Effectiveness of Targeting Patients Undergoing Percutaneous Coronary Intervention for Therapy With Bivalirudin Versus Heparin Monotherapy According to Predicted Risk of Bleeding [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (04): : 358 - U47
- [2] Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI [10.1016/j.jacc.2014.10.011, 10.1016/j.jacc.2014.09.017, 10.1016/j.jacc.2014.09.016, 10.1161/CIR.0000000000000134]
- [3] [Anonymous], AM COLL CARD C 15 SA
- [4] Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
- [10] Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) : 1792 - 1800